drugset / Trial / NCT00355719

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients

NCT00355719

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the influence of nevirapine in exposure to atazanavir boosted with ritonavir, in steady state equilibrium, in HIV-infected adult patients.

Timeline

Start
2007-01
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified 300 mg
Subject Nevirapine Small molecule 200 mg
Background Ritonavir Other / unclassified 100 mg